🎗 Beltran Lab News 🎗
January 2024 - HPN328 is a Tri-Specific antibody that can simultaneously recognize human T cells and tumor cells that express DLL3, a specific tumor antigen in neuroendocrine cancers including prostate cancer. Dr. Beltran presents the interim Phase 1 results showing that HPN328 is well tolerated and clinically active in patients.
January 2024 - The Beltran lab team, led by Himisha Beltran, MD and in collaboration with the University of Trento, Italy, have developed a blood test that distinguishes a neuroendocrine subtype of advanced prostate cancer. Described in Cancer Discovery, this test can reliably detect NEPC and differentiate it from CRPC-adenocarcinoma (CRPC-adeno). Read more here.
December 2023 - Congratulations to Balaji, who was awarded a 2023 CURE Mentor Award!! Mentor to Kenny Weng, who said of Balaji: "He provides a welcoming environment where the mentee has leeway to fail and learn more from the experiment. It is a great place to start one's research journey."
|
December 2023 - Check out our latest News and Views in Nature Cell Biology. Here is link to full text: https://rdcu.be/dsJN3
|
November 2023 - Congratulations to Yasutaka on the publication of his article on how the treatment strategy for certain advanced prostate cancers shows promise in preclinical models. The article was published in the November 15 issue of Science Translational Medicine.
|
November 2023 - Congratulations to Dr. Hiroshi Hongo who was awarded a fellowship from the Japan Society for the Promotion of Science to support his research. Great job! We are lucky to have you here at the Beltran Lab!!
|
October 2023 - Congratulations to Balaji, recipient of a 2023 PCF Young Investigator Award! His project is entitled "Defining Lineage-Specific PRC2 Action and Rational Co-Targeting of EZH1/2 in Prostate Cancer". Here is the complete list of awardees.
October 2023 - Congratulations to Dr. Beltran whose team was granted a 2022 PCF TACTICAL (Therapy ACceleration To Intercept CAncer Lethality) Award! Here is the full list of awards.
April 2023 - Congratulations to Balaji, Yasutaka, Kenny, and Osasenaga for their review article on the important role of RB1 loss in cancer.
April 2023 - Congratulations to Martin publishing his exciting work on Nature Cancer to address the regulation of PSMA in AR+ and AR- prostate cancer, important for PSMA theranostics.
March 2023 - Balaji presenting his latest work at AACR Prostate
February 2023 - Congratulations to Dr. Beltran for for being awarded the Richard A. Smith Prize to recognize her distinguished and continuing achievement in scientific research. Bravo!!
February 2023 - Congratulations to Dr. Beltran for receiving a prestigious Prostate Cancer Foundation Challenge Award to develop novel immunotherapies for patients with neuroendocrine prostate cancer.
Here is the complete list of Awardees June 2022 - Congratulations to Dr. Mizuno publishing a new paper to address the applications of precision oncology in prostate cancer !
June 2022 - We are excited to have Kenny Weng this summer as a CURE scholar to study targeting cell cycle regulators in prostate cancer. Welcome Kenny!
Feb 2022 - Congratulations to Shengyu winning the first prize for his abstract at 14th Annual Multi-Institutional Prostate Cancer SPORE retreat!
Jan 2022 - Congratulations to Balaji and Martin for receiving prestigious DoD PCRP @CDMRP Early Investigator Research Awards!! Here is the complete list of Awardees.
Aug 2021 - We are delighted to welcome our new research fellow, Dr. Kei Mizuno. Dr. Mizuno will study cell-free DNA in advanced prostate cancer. Welcome Kei!!
June 2021 - We are very glad to welcome Osase Idahor, a very talented student and incoming freshman at Harvard College. He joins our lab this summer as a CURE scholar to develop novel therapeutic strategies for advanced prostate cancer. Welcome Osase!
May 2021 - Congratulations to Dr. Varadha Balaji Venkadakrishnan who was awarded a fellowship from National Cancer Center to support his research. Good job!! We are lucky to have you on our team!
Jan 2021 - Congratulations to Dr. Yasutaka Yamada who published a timely review on neuroendocrine prostate cancer!
Jan 2021 - Congratulations to Dr. Beltran for receiving an inaugural Helen Trailblazer Award funded by The Helen Gurley Brown Foundation in support of advancing the careers of women and cultivating female leaders. With this prestigious award, Dr. Beltran will develop next generation immunotherapies to improve patient care.
Jan 2021 - Congratulations to Dr. Beltran who has been named as a Top Doctor in Boston, along with many colleagues at the Dana-Farber Cancer Institute! Dr. Beltran will continue
to provide her best care for patients to conquer prostate cancer. Nov 2020 - Dr. Beltran published a new perspective on Nature Cancer to address the scope of precision medicine in treating metastatic prostate cancer. Congratulations!
July 2020 - Antony successfully defended his thesis and graduated from medical school. Congratulations!! We are all proud of you 👍
April 2020 - Dr. Beltran received a prestigious R01 grant converted to R37 funded by the National Cancer Institute to continue studying neuroendocrine prostate cancer. Congratulations!! 🎉
Feb 2020 - The Beltran lab welcomes Lisa (left) and Mica (right) to our team!
|